Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 3C-like proteinase (3CLpro), also known as main protease (Mpro) or nonstructural protein 5 (nsp5), is a cysteine protease essential for the life cycle of coronaviruses. It cleaves viral polyproteins at multiple conserved sites, generating functional proteins required for viral replication. Its crucial role and absence from host cells make it an attractive target for antiviral drug development. Inhibitors can halt virus replication, but safety concerns include off-target effects and potential resistance development.
Inhibition of viral polyprotein processing, leading to disruption of viral replication.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 3C-like Proteinase (3CLpro).